Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWD.
Kizlik-Masson C, Peyron I, Gangnard S, Le Goff G, Lenoir SM, Damodaran S, Clavel M, Roullet S, Regnault V, Rauch A, Vincent F, Jeanpierre E, Dupont A, Ternisien C, Donnet T, Christophe OD, van Belle E, Denis CV, Casari C, Susen S, Lenting PJ. Kizlik-Masson C, et al. Among authors: van belle e. Blood. 2023 Mar 23;141(12):1457-1468. doi: 10.1182/blood.2022017569. Blood. 2023. PMID: 36564031 Free article.
[TAVR : Imaging for an optimal femoral approach].
Vincent F, Denimal T, Delhaye C, Pamart T, Pontana F, Van Belle E. Vincent F, et al. Among authors: van belle e. Ann Cardiol Angeiol (Paris). 2022 Dec;71(6):413-416. doi: 10.1016/j.ancard.2022.10.003. Epub 2022 Oct 29. Ann Cardiol Angeiol (Paris). 2022. PMID: 36404521 French.
When Anatomy Is Small, Does the Design Matter?
Van Belle E, Delhaye C, Vincent F. Van Belle E, et al. JACC Cardiovasc Interv. 2023 Feb 27;16(4):441-443. doi: 10.1016/j.jcin.2023.01.004. JACC Cardiovasc Interv. 2023. PMID: 36858663 Free article. No abstract available.
Negative Impact of TET2 Mutations on Long-Term Survival After Transcatheter Aortic Valve Replacement.
Lassalle F, Duployez N, Vincent F, Rauch A, Denimal T, Rosa M, Labreuche J, Dombrowicz D, Staels B, Preudhomme C, Susen S, Van Belle E, Dupont A. Lassalle F, et al. Among authors: van belle e. JACC Basic Transl Sci. 2023 Jul 19;8(11):1424-1435. doi: 10.1016/j.jacbts.2023.04.010. eCollection 2023 Nov. JACC Basic Transl Sci. 2023. PMID: 38093739 Free PMC article.
Transcatheter aortic valve implantation using the SAPIEN 3 valve to treat aortic regurgitation: The French multicentre S3AR study.
Delhomme C, Urena M, Zouaghi O, Campelo-Parada F, Ohlmann P, Rioufol G, Van Belle E, Pinaud F, Meneveau N, Staat P, Morel O, Derimay F, Vincent F, Rouleau F, Brochet E, Chong-Nguyen C, Himbert D. Delhomme C, et al. Among authors: van belle e. Arch Cardiovasc Dis. 2023 Feb;116(2):98-105. doi: 10.1016/j.acvd.2022.12.003. Epub 2023 Jan 9. Arch Cardiovasc Dis. 2023. PMID: 36707263 Free article.
BAlloon expandable vs. SElf expanding transcatheter vaLve for degenerated bioprosthesIs: design and rationale of the BASELINE trial.
Nuis RJ, van Belle E, Teles R, Blackman D, Veulemans V, Santos IA, Pilgrim T, Tarantini G, Saia F, Iakovou I, Mascherbauer J, Vincent F, Geleijnse M, Sathananthan J, Wood D, Makkar R, Van Mieghem NM; BASELINE Investigators. Nuis RJ, et al. Among authors: van belle e, van mieghem nm. Am Heart J. 2023 Feb;256:139-147. doi: 10.1016/j.ahj.2022.11.013. Epub 2022 Nov 19. Am Heart J. 2023. PMID: 36410441 Free article. Clinical Trial.
Fractional flow reserve or 3D-quantitative-coronary-angiography based vessel-FFR guided revascularization. Rationale and study design of the prospective randomized fast III trial.
Scoccia A, Byrne RA, Banning AP, Landmesser U, Van Belle E, Amat-Santos IJ, Sabaté M, Tijssen JGP, Spitzer E, Daemen J. Scoccia A, et al. Among authors: van belle e. Am Heart J. 2023 Jun;260:1-8. doi: 10.1016/j.ahj.2023.02.003. Epub 2023 Feb 14. Am Heart J. 2023. PMID: 36796573 Free article.
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.
Baumbach A, van Royen N, Amat-Santos IJ, Hudec M, Bunc M, Ijsselmuiden A, Laanmets P, Unic D, Merkely B, Hermanides RS, Ninios V, Protasiewicz M, Rensing BJWM, Martin PL, Feres F, De Sousa Almeida M, van Belle E, Linke A, Ielasi A, Montorfano M, Webster M, Toutouzas K, Teiger E, Bedogni F, Voskuil M, Pan M, Angerås O, Kim WK, Rothe J, Kristić I, Peral V, Garg S, Elzomor H, Tobe A, Morice MC, Onuma Y, Soliman O, Serruys PW; LANDMARK trial investigators. Baumbach A, et al. Among authors: van belle e. Lancet. 2024 May 22:S0140-6736(24)00821-3. doi: 10.1016/S0140-6736(24)00821-3. Online ahead of print. Lancet. 2024. PMID: 38795719
320 results